@Article{Osmola2019,
journal="Medycyna Paliatywna/Palliative Medicine",
issn="2081-0016",
volume="11",
number="4",
year="2019",
title="A rare manifestation of chronic lymphocytic leukaemia – leukaemia cutis treated with ibrutinib",
abstract="Skin infiltration by leukaemia (leukaemia cutis – LC) in chronic lymphocytic leukaemia (CLL) occurs in less than 5% of affected patients. It is significantly less common than skin cancers complicating the course of CLL, with an incidence of up to 20%, and non-specific skin lesions. Therefore, it is crucial to perform additional diagnostic tests to establish the aetiology of skin lesions in CLL patients.  In this report, we present a case of a 60-year-old woman with CLL, in whom diffuse skin lesions were observed seven years after diagnosis, histologically confirmed as CLL infiltrates, and who responded well to treatment with ibrutinib.",
author="Osmola, Małgorzata
and Gierej, Beata
and Waszczuk-Gajda, Anna
and Kłosowicz, Agata
and Hałaburda-Rola, Marta
and Jędrzejczak, Wiesław Wiktor
and Basak, Grzegorz
and Ziarkiewicz-Wróblewska, Bogna",
pages="180--183",
doi="10.5114/pm.2019.93186",
url="http://dx.doi.org/10.5114/pm.2019.93186"
}